Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A sensitive proximity ligation assay for active PSA.

Lei Zhu1, Hannu Koistinen, Ping Wu

  • 1Department of Clinical Chemistry, Biomedicum/Helsinki University Central Hospital, FI-00029 Helsinki, Finland.

Biological Chemistry
|June 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective Human Trypsin Inhibitors from Cyanobacteria.

Journal of applied microbiology·2026
Same author

Human chorionic gonadotropin alpha and beta levels are associated with maternal demographic characteristics and psychosocial measures of stress and discrimination.

Psychoneuroendocrinology·2026
Same author

Highlights of the FEBS3+ meeting Exploring molecular frontiers.

FEBS open bio·2026
Same author

Prostate cancer risk-associated single-nucleotide polymorphisms impact the conformational dynamics of prostate-specific antigen.

BMC biology·2025
Same author

Altered Glycosylation of PSA in Prostate Cancer Tissue.

The Prostate·2025
Same author

A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer.

Nature communications·2024

This study developed a highly sensitive assay to detect active prostate-specific antigen (PSA), improving prostate cancer diagnosis. The new proximity ligation assay offers better accuracy than previous methods for active PSA detection.

Area of Science:

  • Biochemistry
  • Oncology
  • Immunology

Background:

  • Prostate-specific antigen (PSA) is a key biomarker for prostate cancer, but its diagnostic utility is limited by cross-reactivity with non-malignant conditions.
  • Circulating PSA exists in free and complexed forms; specific detection of active PSA can enhance diagnostic accuracy.

Purpose of the Study:

  • To develop a highly sensitive assay for enzymatically active PSA using proximity ligation.
  • To improve the differentiation of prostate cancer from benign prostatic conditions.

Main Methods:

  • Implementation of a proximity ligation assay utilizing a PSA-binding peptide and antibody.
  • Development of a novel immunopeptidometric assay for active PSA detection.

Main Results:

Related Experiment Videos

  • The proximity ligation assay achieved a sensitivity of 0.07 microg/l, a tenfold improvement over previous methods.
  • The assay demonstrated high specificity, with no cross-reactivity to inactive proPSA or human kallikrein 2 (hK2).

Conclusions:

  • Proximity ligation enables the development of highly sensitive immunopeptidometric assays for active PSA.
  • This approach holds promise for creating specific assays for active forms of other proteases, advancing diagnostic capabilities.